NCT02070471View on ClinicalTrials.gov

Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2015

Conditions

ST-segment Elevation Myocardial Infarction

Interventions

DRUG

Placebo

Placebo

DRUG

LC28-0126 Dose A

LC28-0126 Dose A

DRUG

LC28-0126 Dose B

LC28-0126 Dose B

DRUG

LC28-0126 Dose C

LC28-0126 Dose C

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY